Pfenex and marketing partner Alvogen have launched the firm’s PF708 version of teriparatide in the US.
Pfenex And Alvogen Launch US Teriparatide
First Pfenex Launch Comes As Firm Waits For Equivalence Designation
Pfenex marketing partner Alvogen has introduced the firm’s Bonsity version of teriparatide in the US. Representing the first Pfenex-developed product to hit the market, the launch comes as the companies are still awaiting a formal equivalence designation from the FDA.
